Cologuard® revenue increased 158 percent to $73 million during third quarter
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/5/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
Exact Sciences (EXAS) PT Raised to $61 at Craig-Hallum
October 31, 2017 7:24 AM EDTCraig-Hallum analyst Kevin Ellich raised his price target on Exact Sciences (NASDAQ: EXAS) to $61.00 while maintaining a Buy rating following strong beat and raise results.
... MoreExact Sciences (EXAS) Tops Q3 EPS by 7c; Guides Above Views
October 30, 2017 4:09 PM EDTExact Sciences (NASDAQ: EXAS) reported Q3 EPS of ($0.23), $0.07 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $72.6 million versus the consensus estimate of $65.02 million.
GUIDANCE:
Exact Sciences sees FY2017 revenue of $254-257 million, versus the consensus of... More
